Our Clinical Research team is highly experienced and is presently involved in conducting Phase I to Phase IV trials in support of our in-license products and R&D pipeline. 

Scientific papers based on these clinical studies have been published in reputed peer reviewed indexed national / international journals to encourage science based communications.

Over the years, we have developed expertise & gathered experience in performing varied clinical studies for the introduction of new innovative therapies into our markets of interest. Our scientists also have expertise in developing difficult to make technology intensive products including rational Fixed Dose combinations, Novel Drug Delivery Systems (NDDS) and New Chemical Entities (NCEs).

As a partner of choice in in-licensing & out-licensing activity, we have a long demonstrated history of respecting IP.